ClinicalTrials.gg
Sign In

Fallopian Tube Neoplasms clinical trials

The registry lists 835 studies for Fallopian Tube Neoplasms across more than 10 countries. 131 are recruiting or about to start. 287 of them are mainly about Fallopian Tube Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

ClinicalTrials.gov finds 1,009 studies for Fallopian Tube Neoplasms. How that becomes 833 here

This page counts the studies the registry files under Fallopian Tube Neoplasms, and those it files under no condition that list Fallopian Tube Neoplasmsthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 1,009Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −4List Fallopian Tube Neoplasms as a condition, but the registry did not file them under itMost often written as “Epithelial Ovarian Cancer, Fallopian Tube or Peritoneum” (3), “Stage II Fallopian Tube Cancer AJCC v6 and v7” (1), and “Stage IIA Fallopian Tube Cancer AJCC v6 and v7” (1). The registry filed them under other conditions only, most often Carcinoma, Ovarian Epithelial (3) and Anemia (1).
  3. −172Match it another way33 name it in the title and 139 by a synonym or other text the search reads.
  4. 833The count on this page5 of them list Fallopian Tube Neoplasms in their own words; the registry filed them under no condition.

Get an email when these change. Save the Fallopian Tube Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
421
Terminated
111
Recruiting
105
Active, not recruiting
80
Status unknown
55
Withdrawn
34

Phase

Phase 2
383
Phase 1
269
Phase 3
114
Early Phase 1
18
Phase 4
2

Where

United States
589
Canada
86
United Kingdom
76
Spain
70
China
58
Italy
57

Who runs them

National Cancer Institute (NCI) (82) · Gynecologic Oncology Group (41) · M.D. Anderson Cancer Center (36) · Memorial Sloan Kettering Cancer Center (28) · Roswell Park Cancer Institute (16) · Mayo Clinic (15) · Dana-Farber Cancer Institute (15) · Masonic Cancer Center, University of Minnesota (14)

What is being tested here

Drugs under test in Fallopian Tube Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Paclitaxel71573
Bevacizumab51249
Carboplatin41481
Mirvetuximab soravtansine4514
Raludotatug deruxtecan444
Olaparib3315
Rinatabart sesutecan334
Fluzoparib314
Torvutatug samrotecan323
Cisplatin2321

Drug classes tested here PARP inhibitors 11 open · Antimitotic agents 9 open · Antibody-drug conjugates (ADCs) 6 open · Angiogenesis inhibitors 5 open · Immune checkpoint inhibitors 5 open

Coming up

42phase 3 studies under way
71studies finish main data collection within a year9 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 105 Fallopian Tube Neoplasms studies recruiting now, 87 (83%) set no upper age limit and 10 (10%) stop at 75 or younger. 6 (6%) take children under 18. 79 (75%) are for women only and 0 (0%) for men only; 1 (1%) take healthy volunteers.

Recruiting studies that take each age, of 105
AgeWomenMen
105 (5%)3 (3%)
18103 (98%)26 (25%)
30105 (100%)26 (25%)
40105 (100%)26 (25%)
50105 (100%)26 (25%)
65105 (100%)26 (25%)
75105 (100%)26 (25%)
8593 (89%)26 (25%)

Across all 835 studies, recruiting or not: 5% stop at 75 or younger and 1% at 65; 7% take children; 82% are for women only and 0% for men only; 1% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Fallopian Tube Neoplasms studies take

Of 125 phase 2 interventional studies under Fallopian Tube Neoplasms, half reached primary completion within 56 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 154 mo36–83 · 96 studies42 mo31–57 · 31 studies69 mo38–87 · 65 studies
Phase 1/270 mo56–110 · 37 studies——
Phase 256 mo42–90 · 125 studies—63 mo45–91 · 98 studies
Phase 359 mo38–109 · 54 studies——
Interventional, no phase83 mo27–94 · 28 studies——
Observational64 mo35–151 · 45 studies—74 mo35–151 · 37 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Started recruiting3

Results posted2

Stopped3

Newly registered4

Studies

Recruiting first, then most recently updated. Showing 50 of 835. Browse all 835 → or search them.